Clinical Trial Search

Primary: Ratio of Spike-Wave Index (SWI) During First Hour of Nonrapid Eye Movement (NREM) Sleep at Week 6 — -0.02; 0.01 Log-transformed ratio — p=0.4326

Primary: FFR 6 Months After SAVR/TAVI. — -0.0279 ratio

Primary: Number of Participants That Experienced Adverse Events (AEs) and Serious Adverse Events (SAEs) — 8; 0 Participants

Primary: Thrombus Volume (mm^3) — 9.8; 4.8; 7.7 mm^3

Primary: Change From Baseline in Post Traumatic Stress Disorder Symptoms — -9.9; -2.3 score on a scale

Primary: Weight Loss — 3.1; 2.8 % of weight loss

Primary: Tolerability of the Micro Expression Training Task in Individuals With High Anxiety — 5; 6 Participants

Primary: Number of Emergency Department Visits or Hospital Admissions — 0.25; 0.21 events per 100 person-days alive

Primary: Satisfaction on Ramp Descent With the New Microprocessor-controlled Prosthetic Knee (MPK) — 1; 0; 3; 4 Participants

Primary: Number of Participants Reporting One or More Treatment-emergent Adverse Events (TEAEs) and Based on TEAEs Severity — 4; 2; 4; 3 Participants

Primary: Rate of COVID-19 Vaccination (6 Month) — 251; 130 Participants

Primary: Screening Completion Rate — 46; 88; 132; 131 Participants

Primary: Cognitive Dissonance — 2.23; 3.32; 4.33; 3.67 units on a scale — p=.003

Primary: Change in the Percent Time Glucose is ≥ 140 mg/dL From Pre- to Post-intervention — 0.38; -0.49 Percent time glucose >= 140mg/dL

Primary: Learning Rate as Indexed by Change in the Precision of Visuomotor Grip Force Adjustment (i.e., Reduction of Precision Error in Force Adjustment) — -1.48; 0.303…